Skip to content
This website uses cookies to help us understand the way visitors use our website. We can't identify you with them and we don't share the data with anyone else. If you click Reject we will set a single cookie to remember your preference. Find out more in our privacy policy.

First phase of AAC Pathway Transformation Fund launched

1 August 2019

The AHSN Network is supporting the launch of the first phase of the Accelerated Access Collaborative Pathway Transformation Fund (PTF), which was announced by government in July 2017.

Funding through the new PTF will be made available to help NHS organisations integrate the rapid uptake products into everyday practices, supporting an improvement in equality of access and reducing health inequalities that exist regarding diagnosis and disease management.

The PTF can help providers overcome more practical obstacles to deploying these products, such as: training staff on how to use new equipment; pathway redesign and/or business support expertise; providing specialist nurses/clinical staff needed to implement a new part of the procedure; or covering double running costs.

Phase One

This is the first phase of AAC Pathway Transformation Fund, focusing on three of the AAC rapid uptake products (UroLift, placental growth factor-based testing and high-sensitivity troponin testing in an under three-hour protocol), with a closing date of midnight on 16 August. We strongly encourage any Providers wishing to adopt any of these rapid uptake products to apply.

We anticipate that awards and contracts for the successful applicants will be in place by early September 2019.

To request an application form please contact your local AHSN in the first instance to discuss with the relevant AHSN lead for each product. If you are unsure of your local AHSN, please email for clarification.

Phase Two

We plan to open phase 2 of the PTF in late September and close in October and further details will be made available in September.

For further enquiries please contact .